| scholarly article | Q13442814 |
| P2093 | author name string | V Wong | |
| C P Pang | |||
| K Y Chan | |||
| J Hui | |||
| L Y Chan | |||
| C W Lam | |||
| S F Tong | |||
| C H Ko | |||
| T F Fok | |||
| Y M Lo | |||
| W L Yeung | |||
| P M Poon | |||
| I F Lo | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| Rett syndrome | Q917357 | ||
| autism spectrum disorder | Q1436063 | ||
| P304 | page(s) | E41 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Medical Genetics | Q14640281 |
| P1476 | title | Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome | |
| P478 | volume | 37 |
| Q28572490 | A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing |
| Q30718645 | A decade of high-resolution liquid chromatography of nucleic acids on styrene-divinylbenzene copolymers |
| Q31126099 | A role for MeCP2 in switching gene activity via chromatin unfolding and HP1γ displacement |
| Q48573215 | Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome |
| Q37962183 | Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with neurodevelopmental disabilities |
| Q34733527 | Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype |
| Q50305292 | Autism spectrum disorders associated with X chromosome markers in French-Canadian males |
| Q22242030 | Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist |
| Q48494390 | Balanced X chromosome inactivation patterns in the Rett syndrome brain |
| Q47773665 | Brief report: emerging services for children with autism spectrum disorders in Hong Kong (1960-2004). |
| Q46217072 | Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions |
| Q28257072 | Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome |
| Q26829214 | DNA modifications: function and applications in normal and disease States |
| Q95841115 | Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia |
| Q27025729 | Disease mutations in disordered regions--exception to the rule? |
| Q36286566 | Does genotype predict phenotype in Rett syndrome? |
| Q29616326 | Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes |
| Q22337143 | Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. |
| Q38681930 | Epigenetics of Autism Spectrum Disorder |
| Q39336050 | Epigenetics, nutrition and mental health. Is there a relationship? |
| Q37754018 | Evolving role of MeCP2 in Rett syndrome and autism |
| Q30445073 | Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies |
| Q39126183 | Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate |
| Q35770888 | GABA system dysfunction in autism and related disorders: from synapse to symptoms |
| Q38900958 | Genetic Studies in Autism |
| Q33312371 | High levels of MeCP2 depress MHC class I expression in neuronal cells |
| Q28207072 | Identification of MeCP2 mutations in a series of females with autistic disorder |
| Q39069727 | Identification of two novel Shank3 transcripts in the developing mouse neocortex |
| Q28505346 | Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome |
| Q35838075 | Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research |
| Q30367333 | Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome. |
| Q36286534 | MECP2 abnormality phenotypes: clinicopathologic area with broad variability |
| Q51935037 | MECP2 mutation analysis in patients with mental retardation. |
| Q43960963 | Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome |
| Q44784279 | MeCP2 deficiency is associated with impaired microtubule stability |
| Q34764182 | MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. |
| Q36820823 | Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism |
| Q35593898 | Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons |
| Q41934849 | Molecular screening of MECP2 gene in a cohort of Lebanese patients suspected with Rett syndrome: report on a mild case with a novel indel mutation. |
| Q28188406 | Mutations and polymorphisms in the human methyl CpG-binding protein MECP2 |
| Q24534159 | Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation |
| Q33647511 | Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes |
| Q35200175 | Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome |
| Q41919817 | Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability |
| Q34490485 | Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes |
| Q35671678 | Paradoxical role of methyl-CpG-binding protein 2 in Rett syndrome. |
| Q64103670 | Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders |
| Q33283941 | Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation |
| Q36145999 | Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia |
| Q36222710 | Regulatory functions and pathological relevance of the MECP2 3'UTR in the central nervous system. |
| Q38194967 | Rett syndrome and MeCP2. |
| Q34402592 | Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission |
| Q43674538 | Rett syndrome from quintuple and triple deletions within the MECP2 deletion hotspot region |
| Q36417908 | Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. |
| Q34499035 | Rett syndrome: a Rosetta stone for understanding the molecular pathogenesis of autism |
| Q48650852 | Rett syndrome: clinical manifestations in males with MECP2 mutations |
| Q50310996 | Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders |
| Q33915332 | Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice |
| Q38579848 | Review of evolution of clinical, training and educational services and research program for autism spectrum disorders in Hong Kong |
| Q22251430 | Searching for ways out of the autism maze: genetic, epigenetic and environmental clues |
| Q59133547 | Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder |
| Q28212831 | Sodium channels SCN1A, SCN2A and SCN3A in familial autism |
| Q58798944 | Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome |
| Q50771571 | The Goldilocks effect. |
| Q27500386 | The Intense World Theory – A Unifying Theory of the Neurobiology of Autism |
| Q51909619 | The MECP2 duplication syndrome. |
| Q38579867 | The complex genetics in autism spectrum disorders |
| Q50312927 | The diagnosis of autism in a female: could it be Rett syndrome? |
| Q22250987 | The genetics of autistic disorders and its clinical relevance: a review of the literature |
| Q38314584 | Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS). |
| Q47261381 | Trisomy 21 and Rett syndrome: a double burden |
| Q35680677 | Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders |
| Q33911020 | X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome |
Search more.